Clinical Trial Update: A Study of Thalidomide Plus Dexamethasone (Thal-Dex) Versus DOXIL plusThalidomide Plus Dexamethasone (DOXIL -Thal-Dex) in Patients With Newly Diagnosed Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Thalidomide plus Dexamethasone (Thal-Dex) to DOXIL plus Thal-Dex in newly diagnosed multiple myeloma. The study completed and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Doxil (liposomal doxorubicin)
• Thalidomide (thalidomide)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2008-11-27